Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 17/20 | 0.48 |
| ▸ | HTR1D | P28221 | 5/20 | 0.44 |
| ▸ | HTR1B | P28222 | 5/20 | 0.44 |
| ▸ | HTR2C | P28335 | 4/20 | 0.44 |
| ▸ | HTR1A | P08908 | 4/20 | 0.44 |
| ▸ | HTR7 | P34969 | 1/20 | 0.44 |
| ▸ | HTR2B | P41595 | 1/20 | 0.44 |
| ▸ | GUSB | P08236 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1775143 | 0.99 | HTR6 (0.47) | HTR6HTR1DHTR1BHTR2CHTR1A | |
| SCHEMBL1774831 | 0.89 | HTR6 (0.50) | HTR6HTR1DHTR1BHTR2CHTR1A | |
| SCHEMBL1775888 | 0.89 | HTR6 (0.46) | HTR6HTR1DHTR1BHTR2CHTR1A | |
| Hydrochloric Acid SCHEMBL1774134 | 0.88 | HTR6 (0.49) | HTR6HTR1DHTR1BHTR2CHTR1A | |
| Hydrochloric Acid SCHEMBL1775502 | 0.88 | HTR6 (0.45) | HTR6HTR1DHTR1BHTR2CHTR1A | |
| SCHEMBL1777202 | 0.87 | HTR6 (0.48) | HTR6HTR1DHTR1BHTR2CHTR1A | |
| SCHEMBL1776158 | 0.86 | HTR6 (0.54) | HTR6HTR1DHTR1BHTR2CHTR1A | |
| Hydrochloric Acid SCHEMBL1775919 | 0.86 | HTR6 (0.47) | HTR6HTR1DHTR1BHTR2CHTR1A | |
| Hydrochloric Acid SCHEMBL1776342 | 0.86 | HTR6 (0.53) | HTR6HTR1DHTR1BHTR2CHTR1A | |
| SCHEMBL1775636 | 0.85 | HTR6 (0.47) | HTR6HTR1DHTR1BHTR2CHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7943639-B2 | Such as 6-benzenesulfonyl-4-piperazin-1-yl-quinoline hydrochloride; for treatment of central nervous system and/or 5- HT6 receptor related disorders; for weight gain/loss | PROXIMAGEN LIMITED (GB) | 2011-05-17 | — | — | US | claimed |